Rupee recovers 21 paise to 74.86 against U.S. dollar in early trade

Broncos Fifth Quarter: Offense’s work on third down was first rate vs. Chargers – The Denver Post

Upon Further Review

Four Key Numbers

Talking Points

Extra points

Forget Bloody Marys. This Brunch Has Caviar, and Lots of It.

At Hancock St. in the West Village, an uncommonly affordable caviar service is available.

Send any friend a story

As a subscriber, you have 10 gift articles to give each month. Anyone can read what you share.


By Florence Fabricant

Opinion | What Europe Can Teach Us About Jobs

Send any friend a story

As a subscriber, you have 10 gift articles to give each month. Anyone can read what you share.

By Paul Krugman

Opinion Columnist

Opinion | What ‘My Body, My Choice’ Means to the Right

Send any friend a story

As a subscriber, you have 10 gift articles to give each month. Anyone can read what you share.

By Michelle Goldberg

Opinion Columnist

UnitedHealth Sees FY22 Profit Below View

UnitedHealth Group (UNH) said that it expects net earnings to be in the range of $20.20 – $20.70 per share, and adjusted net earnings of $21.10 – $21.60 per share for fiscal year 2022. Analysts polled by Thomson Reuters expect the company to report earnings of $21.65 per share for fiscal year 2022. Analysts’ estimates typically exclude special items.

The company projects revenues to be between $317 billion and $320 billion for fiscal year 2022. Analysts expect revenue of $311.91 billion for fiscal year 2022.

Looking ahead for fiscal year 2021, the company now projects net earnings to be in the range of $17.80 – $17.95 per share, adjusted net earnings of $18.75 – $18.90 per share and revenues of about $287 billion. Analysts expect the company to report earnings of $18.85 per share and revenues of $286.02 billion for fiscal year 2021.

The company said in October that it expected net earnings to be in a range of $17.70 to $17.95 per share and adjusted earnings of $18.65 to $18.90 per share for fiscal year 2021.

Sensex jumps over 500 points in opening session; Nifty tops 17,200

Equity benchmark Sensex jumped over 500 points in early trade on Tuesday led by gains in index majors TCS, Infosys and Bajaj Finance.

The 30-share index was trading 504.75 points or 0.88 per cent higher at 57,765.33 in initial deals. Similarly, the Nifty rose 149.65 points or 0.88 per cent to 17,203.60.

PowerGrid was the top gainer in the Sensex pack, rising around 5 per cent, followed by Axis Bank, Tech Mahindra, Bajaj Finance, Bajaj Finserv, SBI, TCS and Infosys.

On the other hand, Dr Reddy’s was the only Sensex constituent trading with losses.

In the previous session, the 30-share BSE index gained 153.43 points or 0.27 per cent to finish at 57,260.58. And the broader NSE Nifty edged higher by 27.50 points or 0.16 per cent to 17,053.95.

Foreign institutional investors (FIIs) were net sellers in the capital market, as they sold shares worth Rs 3,332.21 crore on Monday, as per exchange data.

Elsewhere in Asia, bourses in Shanghai and Tokyo were trading with gains in mid-session deals, while Hong Kong and Seoul stock exchanges were in the red.

Stock exchanges in the US ended with gains in the overnight session.

Meanwhile, international oil benchmark Brent crude rose 0.72 per cent to USD 73.97 per barrel.

Rupee recovers 21 paise to 74.86 against U.S. dollar in early trade

The rupee on Monday dived 18 paise to close at a five-week low of 75.07 against the U.S. dollar on worries over the new coronavirus variant.

The rupee recovered 21 paise to 74.86 against the U.S. dollar in opening trade on Tuesday, as positive domestic equities and a weak American currency in the overseas markets boosted investor sentiments.

At the interbank foreign exchange, the rupee opened on a strong note at 74.91, then surged higher to 74.86 against the American dollar, registering a rise of 21 paise in the early deals.

The rupee on Monday dived 18 paise to close at a five-week low of 75.07 against the U.S. dollar on worries over the new coronavirus variant.

The appreciation bias in the rupee might be curtailed, as investor concern has resurfaced about how much damage the new Omicron coronavirus variant may unleash on the economy, traders said.

The dollar index, which gauges the greenback’s strength against a basket of six currencies, slipped 0.21 % to 96.14.

On the domestic equity market front, the 30-share Sensex was trading 666.58 points or 1.16% higher at 57,927.16, while the broader NSE Nifty jumped 199.65 points or 1.17% to 17,253.60.

Global oil benchmark Brent crude futures advanced 0.63% to $ 73.90 per barrel.

Foreign institutional investors were net sellers in the capital market on Monday, as they offloaded shares worth ₹ 3,332.21 crore, according to exchange data.